share_log

申联生物:国信证券股份有限公司关于申联生物医药(上海)股份有限公司使用部分闲置募集资金进行现金管理的核查意见

Shenlian Biotech: Opinions of Guoxin Securities Co., Ltd. on the verification of the use of some idle funds raised by Shenlian Biopharmaceuticals (Shanghai) Co., Ltd. for cash management

SZSI ·  Oct 31, 2024 01:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more